Summary
Updated Aug 31, 2026
Delos M. Cosgrove is Director of Hims & Hers Health, Inc. (HIMS). 4 SEC Form 4 filings on record going back to 2025, most recently on 14 August 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Delos M. Cosgrove has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Delos M. Cosgrove files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew Dudum - $23.71M of HIMS open-market activity in the last 12 months
- Oluyemi Okupe - $23.10M of HIMS open-market activity in the last 12 months
- Michael Chi - $3.96M of HIMS open-market activity in the last 12 months
- Soleil Boughton - $1.93M of HIMS open-market activity in the last 12 months
- Patrick Harrison Carroll - $1.34M of HIMS open-market activity in the last 12 months
- David B. Wells - $1.17M of HIMS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Delos M. Cosgrove?
Delos M. Cosgrove is a corporate insider, tracked as Director of Hims & Hers Health, Inc. (HIMS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Delos M. Cosgrove submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Delos M. Cosgrove's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Delos M. Cosgrove and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
